Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

XoNovo

2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of technologies for the treatment of neurodegenerative diseases. The company develops a candidate drug which targets a protein implicated in several neurodegenerative diseases, including alzheimer's disease and batten disease.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 3422 Old Capitol Trail
  • Suite 700
  • Wilmington, DE 19808
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore XoNovo’s full profile, request a free trial.

XoNovo Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 14-Jan-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

XoNovo Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
FutuRx Accelerator/Incubator 000 0000 000000 0

XoNovo Executive Team (4)

Name Title Board
Seat
Contact
Info
Liora Wiksman Chief Executive Officer
Kenneth Hensley Co-Founder & Chief Scientific Officer
Ofir Levi Co-Founder
Rafi Gidron Ph.D Co-Founder & Chairman

XoNovo Board Members (1)

Name Representing Role Since Contact
Info
Rafi Gidron Ph.D Self Co-Founder & Chairman 000 0000